Drug Safety

, Volume 22, Issue 2, pp 103–109 | Cite as

Patient-Oriented Strategies for the Prevention of Drug Interactions

Leading Article


Drug interactions are a common and serious problem arising from polypharmacy. Strategies to reduce the likelihood of the co-prescription of hazardous drug combinations are likely to enhance the quality of care provided for patients requiring polypharmacotherapy. Drugs for which patient-oriented information strategies may decrease the likelihood of drug interactions tend to be those of low therapeutic index, and have interaction potential with other drugs commonly prescribed or available without prescription.


Drug Interaction Terfenadine Astemizole Potential Drug Interaction Flesch Reading Ease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



This work was supported in part by financial grants from the Medical Benefits Fund (MBF) of Australia, and the Special Purposes Trust Fund of the Repatriation General Hospital, Daw Park, South Australia.


  1. 1.
    Strand LM, Morley PC, Cipolle RJ, et al. Drug-related problems: their structure and function. DICP Ann Pharmacother 1999; 24: 1093–7Google Scholar
  2. 2.
    Stanton LA, Peterson GM, Rumble RH, et al. Drug-related admissions to an Australian hospital. J Clin Pharm Ther 1994; 19: 341–7PubMedCrossRefGoogle Scholar
  3. 3.
    Mok H, Mulpeter K, O’Connor P. Drug-drug interactions in the hospital. Ir Med J 1991; 84: 26PubMedGoogle Scholar
  4. 4.
    Jankel CA, Fitterman LK. Epidemiology of drug-drug interactions as a cause of hospital admissions. Drug Saf 1993; 9: 51–9PubMedCrossRefGoogle Scholar
  5. 5.
    Goldberg RM, Mabee J, Chan L, et al. Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population. Am J Emerg Med 1996; 14: 447–50PubMedCrossRefGoogle Scholar
  6. 6.
    Costa AJ. Potential drug interactions in an ambulatory geriatric population. Fam Pract 1991; 8: 234–6PubMedCrossRefGoogle Scholar
  7. 7.
    Cadieux RJ. Drug interactions in the elderly. How multiple drug use increases risk exponentially. Postgrad Med 1989; 86: 179–86PubMedGoogle Scholar
  8. 8.
    Marik PE, Fromm L. A case series of hospitalized patients with elevated digoxin levels. Am J Med 1998; 105: 110–5PubMedCrossRefGoogle Scholar
  9. 9.
    Hamilton RA, Gordon T. Incidence and cost of hospital admissions secondary to drug interactions involving theophylline. Ann Pharmacother 1992; 26: 1507–11PubMedGoogle Scholar
  10. 10.
    Jankel CA, McMillan JA, Martin BA. Effect of drug interactions on outcome of patients receiving warfarin or theophylline. Am J Hosp Pharm 1994; 51: 661–6PubMedGoogle Scholar
  11. 11.
    Atkin PA, Stringer RS, Duffy JB, et al. The influence of information provided by patients in the accuracy of medication records. Med J Aust 1998; 169: 85–8PubMedGoogle Scholar
  12. 12.
    Atkin PA, Finnegan TP, Ogle SJ, et al. Are medication cards useful? Med J Aust 1995; 162: 300–1PubMedGoogle Scholar
  13. 13.
    Sansom LN, editor. Australian pharmaceutical formulary and handbook. 16th ed. Canberra, Australia: Pharmaceutical Society of Australia, 1997Google Scholar
  14. 14.
    Duguid MJ. CPI - education or information? Aust J Hosp Pharm 1994; 24: 229Google Scholar
  15. 15.
    Joseph P. Consumer product information affects us all: IV - medical practitioner view. Aust Prescr 1996; 19: 33–4Google Scholar
  16. 16.
    Fogg S. Consumer product information affects us all: II - consumer view. Aust Presc 1996; 19: 32Google Scholar
  17. 17.
    Baker SJ. Who can read consumer product information? Aust J Hosp Pharm 1997; 27: 126–31Google Scholar
  18. 18.
    Davidson J, Zung WW, Walker JI. Practical aspects of MAO inhibitor therapy. J Clin Psychiatry 1984; 45: 81–4PubMedGoogle Scholar
  19. 19.
    Scalley RD, Kearney E, Jakobs E. Interdisciplinary inpatient warfarin education program. Am J Hosp Pharm 1979; 36: 219–20PubMedGoogle Scholar
  20. 20.
    Walker JI. Use of a patient education booklet to improve compliance with lithium therapy [letter]. Psychosomatics 1981; 22: 51PubMedGoogle Scholar
  21. 21.
    Alderman CP. Medication alert cards to minimise antidepressant drug interactions. Aust J Hosp Pharm 1998; 28: 259–60Google Scholar
  22. 22.
    Lacro JP, Jeste DV. Physical comorbidity and polypharmacy in older psychiatric patients. Biol Psychiatry 1994; 36: 146–52PubMedCrossRefGoogle Scholar
  23. 23.
    Nemeroff CB, DeVane CL, Pollock BG. Newer antidepressants and the cytochrome p450 system. Am J Psychiatry 1996; 153: 311–20PubMedGoogle Scholar
  24. 24.
    Adson DE, Crow SJ, Meller WH, et al. Potential drug interactions on a tertiary-care hospital consultation-liaison psychiatry service. Psychosomatics 1998; 39: 360–5PubMedCrossRefGoogle Scholar
  25. 25.
    McClung HJ, Murray RD, Heitlinger LA. The internet as a source of current patient information. Pediatrics 1998; 101: E2PubMedCrossRefGoogle Scholar
  26. 26.
    Dowe MC, Lawrence PA, Carlson J, et al. Patients’ use of health teaching materials at three readability levels. Appl Nurs Res 1997; 10: 86–93PubMedCrossRefGoogle Scholar
  27. 27.
    Monk D. Who can read consumer product information [letter]. Aust J Hosp Pharm 1997; 27: 250–1Google Scholar
  28. 28.
    Tasker J, Parker S, Friedel H, et al. Who can read consumer product information [letter]. Aust J Hosp Pharm 1997; 27: 251–2Google Scholar
  29. 29.
    Sless D. Who can read consumer product information [letter]. Aust J Hosp Pharm 1997; 27: 252–3Google Scholar
  30. 30.
    Baker S. Who can read consumer product information [letter]. Aust J Hosp Pharm 1997; 27: 253–4Google Scholar
  31. 31.
    Lasater L, Mehler PS. The illiterate patient: screening and management. Hosp Pract 1998; 33: 169–70Google Scholar
  32. 32.
    Fogarty JS. Reactance theory and patient noncompliance. Soc Sci Med 1997; 45: 1277–88PubMedCrossRefGoogle Scholar
  33. 33.
    Feste C, Anderson RM. Empowerment: from philosophy to practice. Patient Educ Couns 1995; 26: 139–44PubMedCrossRefGoogle Scholar
  34. 34.
    Chaplin R, Kent A. Informing patients about tardive dyskinesia. Controlled trial of patient education. Br J Psychiatry 1998; 172: 78–81PubMedCrossRefGoogle Scholar
  35. 35.
    Arthur VA. Written patient information: a review of the literature. J Adv Nurs 1995; 21: 1081–6PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 2000

Authors and Affiliations

  1. 1.Departments of Pharmacy and PsychiatryRepatriation General HospitalDaw Park, Adelaide, South AustraliaAustralia

Personalised recommendations